D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Microsoft
MSFT
|
+$549M |
| 2 |
Tesla
TSLA
|
+$538M |
| 3 |
Pinduoduo
PDD
|
+$357M |
| 4 |
Intel
INTC
|
+$261M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$255M |
Top Sells
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$398M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$300M |
| 3 |
Procter & Gamble
PG
|
+$281M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 5 |
JPMorgan Chase
JPM
|
+$250M |
Sector Composition
| 1 | Technology | 20.4% |
| 2 | Healthcare | 13.71% |
| 3 | Financials | 11.95% |
| 4 | Consumer Discretionary | 11.45% |
| 5 | Industrials | 7.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Stride
LRN
$6.03B
| $1.38M | ﹤0.01% |
+44,250
| New | +$1.38M |
|
2102
MYR Group
MYRG
$2.7B
| $1.38M | ﹤0.01% |
15,029
+7,433
| +98% | +$684K |
|
2103
Quad
QUAD
$336M
| $1.38M | ﹤0.01% |
337,358
-6,476
| -2% | -$26.4K |
|
|
DSAQ
2104
DELISTED
Direct Selling Acquisition Corp.
DSAQ
| $1.37M | ﹤0.01% |
133,334
| – | – |
|
2105
Amneal Pharmaceuticals
AMRX
$3.09B
| $1.37M | ﹤0.01% |
688,837
+427,987
| +164% | +$852K |
|
2106
Praxis Precision Medicines
PRAX
$818M
| $1.37M | ﹤0.01% |
38,295
+19,358
| +102% | +$691K |
|
2107
CryoPort
CYRX
$435M
| $1.36M | ﹤0.01% |
+78,623
| New | +$1.36M |
|
2108
Metals Acquisition
MTAL
$1.01B
| $1.36M | ﹤0.01% |
136,300
| – | – |
|
2109
CarParts.com
PRTS
$43.2M
| $1.36M | ﹤0.01% |
217,801
+142,635
| +190% | +$893K |
|
2110
Starwood Property Trust
STWD
$7.5B
| $1.36M | ﹤0.01% |
74,377
-58,711
| -44% | -$1.08M |
|
|
WEL
2111
DELISTED
Integrated Wellness Acquisition Corp
WEL
| $1.36M | ﹤0.01% |
132,350
| – | – |
|
2112
Scholastic
SCHL
$697M
| $1.36M | ﹤0.01% |
34,463
+2,597
| +8% | +$102K |
|
2113
Celldex Therapeutics
CLDX
$1.63B
| $1.36M | ﹤0.01% |
30,504
-78,161
| -72% | -$3.48M |
|
2114
Tilly's
TLYS
$59.7M
| $1.36M | ﹤0.01% |
150,135
-12,932
| -8% | -$117K |
|
2115
Varex Imaging
VREX
$479M
| $1.36M | ﹤0.01% |
66,856
+3,542
| +6% | +$71.9K |
|
2116
Infosys
INFY
$70.6B
| $1.35M | ﹤0.01% |
75,203
-24,772
| -25% | -$446K |
|
2117
Designer Brands
DBI
$225M
| $1.34M | ﹤0.01% |
137,210
+93,554
| +214% | +$915K |
|
2118
Kinetik
KNTK
$2.65B
| $1.34M | ﹤0.01% |
40,539
+7,957
| +24% | +$263K |
|
2119
VICI Properties
VICI
$35.3B
| $1.34M | ﹤0.01% |
41,312
+33,001
| +397% | +$1.07M |
|
2120
Gold Fields
GFI
$34.6B
| $1.34M | ﹤0.01% |
129,127
+53,882
| +72% | +$558K |
|
2121
AppFolio
APPF
$9.94B
| $1.33M | ﹤0.01% |
12,637
-5,089
| -29% | -$536K |
|
2122
Full House Resorts
FLL
$124M
| $1.33M | ﹤0.01% |
176,239
+20,249
| +13% | +$152K |
|
2123
Sea Limited
SE
$114B
| $1.32M | ﹤0.01% |
25,400
+11,500
| +83% | +$598K |
|
2124
NovoCure
NVCR
$1.38B
| $1.32M | ﹤0.01% |
18,000
+6,697
| +59% | +$491K |
|
|
FNA
2125
DELISTED
Paragon 28, Inc.
FNA
| $1.32M | ﹤0.01% |
69,031
+43,423
| +170% | +$830K |
|